首页/数据集/Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir

Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir

NIAID Data Ecosystem2026-05-10 收录

抗病毒药物结构生物学

冠状病毒蛋白酶抑制剂

数据链接：

https://www.rcsb.org/structure/8H3K 数据链接链接失效反馈

官方服务：

资源简介：

Crystal Structure of SARS-CoV-2 Main Protease (Mpro) Double Mutant (L50F and E166V) in Complex with Inhibitor Enstrelvir

应用场景：

创建时间：

2026-03-11

冠状病毒蛋白酶抑制剂

分子动力学模拟

Molecular dynamics simulations (500 ps MD at 310 K) of the unrefined crystal structure by Prof. Yang group from ShanghaiTech of novel coronavirus 2019-nCoV protease Mpro in complex with the ligand lop

NIAID Data Ecosystem50

Table_4_In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease.DOC

冠状病毒蛋白酶抑制剂

计算药物筛选

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with very limited treatments so far. Demonstrated with good dr

NIAID Data Ecosystem30

Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with CCF0058981

冠状病毒蛋白酶抑制剂

结构生物学

Crystal structure of SARS-Cov-2 main protease V186F mutant in complex with CCF0058981

NIAID Data Ecosystem20

Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV‑2 Main Protease Inhibitors with High Target Specificity and Low Toxicity

抗病毒药物设计

冠状病毒蛋白酶抑制剂

The continuous spread of SARS-CoV-2 calls for more direct-acting antiviral agents to combat the highly infectious variants. The main protease (Mpro) is an promising target for anti-SARS-CoV-2 drug des

NIAID Data Ecosystem40

PanDDA analysis group deposition -- Crystal structure of PLpro-C111S in complex with Fr16677

冠状病毒蛋白酶抑制剂

蛋白质晶体结构解析

PanDDA analysis group deposition -- Crystal structure of PLpro-C111S in complex with Fr16677

NIAID Data Ecosystem20